Methylphenidate and Zonisamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Zonisamide (zonisamide). Common drug interactions include somnolence among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Zonisamide. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Zonisamide?

Zonisamide has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 11,445 Zonisamide users. Check the latest studies of Zonisamide.



On Aug, 02, 2026

40 people who take Methylphenidate and Zonisamide together, and have interactions are studied.

Methylphenidate and Zonisamide drug interactions.

What are the common drug interactions of Methylphenidate and Zonisamide, by gender? *:

female:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Fall
  3. Ankle fracture
  4. Cardiac disorder
  5. Lung disorder (lung disease)
  6. Alopecia (absence of hair from areas of the body)
  7. Asthenia (weakness)
  8. Blood pressure increased
  9. Chills (felling of cold)
  10. Depression

male:

  1. Fall
  2. Pain
  3. Depressed mood
  4. Enuresis (repeated inability to control urination)
  5. Hypertension (high blood pressure)
  6. Vomiting
  7. Psychomotor hyperactivity (feelings of extreme restlessness)
  8. Suicidal ideation
  9. Hallucination, auditory (perceiving sounds without auditory stimulus)
  10. Persecutory delusion

What are the common drug interactions of Methylphenidate and Zonisamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Ataxia (loss of full control of bodily movements)
  2. Decreased appetite
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Fatigue (feeling of tiredness)
  5. Muscle twitching
  6. Salivary hypersecretion (excess saliva secretion)
  7. Sedation
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Weight decreased

20-29:

  1. Hallucination, auditory (perceiving sounds without auditory stimulus)
  2. Persecutory delusion
  3. Psychotic disorder

30-39:

  1. Fall
  2. Pain
  3. Abnormal sleep-related event
  4. Blood pressure increased
  5. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
  6. Constipation
  7. Defaecation urgency (a sudden compelling urge to defecate)
  8. Gastrointestinal hypermotility (over activity of the intestinal tract)
  9. Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  10. Headache (pain in head)

40-49:

  1. Drug hypersensitivity
  2. Dry mouth
  3. Electrocardiogram qt prolonged

50-59:

  1. Suicide attempt

60+:

  1. Ankle fracture
  2. Cardiac disorder
  3. Gait disturbance
  4. Influenza like illness
  5. Memory impairment
  6. Muscular weakness (muscle weakness)
  7. Rash
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 22 people, 55.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 40.00%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 17.50%
  4. Gait Disturbance: 4 people, 10.00%
  5. Drowsiness: 4 people, 10.00%
  6. Partial Seizures (seizures which affect only a part of the brain at onset): 3 people, 7.50%
  7. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.00%
  8. Depression: 2 people, 5.00%
  9. Birth Control: 2 people, 5.00%
  10. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Zonisamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylphenidate and Zonisamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zonisamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zonisamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate and zonisamide (the active ingredients of Methylphenidate and Zonisamide, respectively), and Methylphenidate and Zonisamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: